Mukka Proteins
- P/E
- 10.5x
- 52-week range
- 18.27 – 33.29
- ROE
- 11%
- ROCE
- 12%
- Sector
- Food Products
- Industry
- Animal Feed
- Listed on
- NSE, BSE
About
Mukka Proteins Limited is an animal protein company, engaged in the production of fish meal, fish oil and fish soluble paste as well as developing alternative proteins such as Black Soldier Fly Insect meal in the animal food segment. Its products include fish meal, fish oil, fish soluble paste, insect meal, insect oil, insect compost and humic acid. It manufactures and supplies fish meal, fish oil and fish soluble paste which are an essential ingredient in the manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds its application in pharmaceutical products (additionally, Omega-3 pills and related products derived from fish oil are gaining importance as high nutrient and healthy dietary supplements), soap manufacturing, leather tanneries and paint industries. It has commercialized insect meal and insect oil (collectively Insect Protein) as an ingredient for aqua feed, animal feed and pet food.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Animal Feed: 9 companies →Mukka Proteins against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)10.5 against a typical 19.5: cheaper than most peers (1st = cheapest).1st of 8
- Sales growth+186.5% against a typical +56.3% from a year earlier.1st of 8
- Profit growth+850% against a typical −20.3% from a year earlier.1st of 8
- Share price, 3 months+6% against a typical +3.3%.3rd of 7
Latest announcements
Exchange filings and their impact on the company.
- 27 Oct 2026Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvalsLow impactPositivePrice −1.9% on 28 OctMukka Proteins secures US FDA facility registration till Dec 2027, enabling access to US customers.
Mukka Proteins has received US FDA facility registration for its facility, confirmed via a certificate from Registrar Corp, USA. The certificate is valid from 1 October 2026 to 31 December 2027. The company says the registration will support operations and help it engage customers and markets that require US FDA registration, opening the door to US exports.
- 9 Oct 2026Commencement of commercial production/operationsMedium impactPositivePrice +0.2% on 12 OctMukka's Oman subsidiary starts commercial fish meal, oil and paste production, adding new Middle East capacity.
Mukka Proteins said its overseas subsidiary, United Gulf Fishery Products LLC, started commercial production of fish meal, fish oil and fish soluble paste on 9 October 2026 at Al Juba, Mahoot in Oman. The company did not disclose capacity or investment, but said the plant will enhance group production capacity and strengthen its presence in the Middle East. The plant is expected to add incremental sales over the next year as utilisation ramps up.
- 9 Oct 2026Giving guarantees/indemnity/ becoming a surety for third partyMedium impactNeutralPrice +0.2% on 12 OctMukka to guarantee up to Rs 73.6 cr of bank loans for its Oman subsidiary.
Mukka Proteins said its board on 9 October 2026 approved a corporate guarantee, standby letter of credit and fixed-deposit security of up to Rs 73.58 crore for its Oman subsidiary United Gulf Fishery Products LLC. The support will secure credit facilities to be taken by the subsidiary from HDFC Bank. The guarantee will be a contingent liability for Mukka and will help fund the subsidiary's business, with recovery rights against the subsidiary if invoked.
- 6 Oct 2026Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvalsLow impactPositivePrice +1.1% that dayMukka gets US organic clearance for its Eco Sphere fertilizer, opening a small new export channel.
Mukka Proteins received a USDA NOP Inputs Attestation from ECOCERT S.A.S., France, for its Eco Sphere Organic Fertilizer, confirming it is suitable for use in organic farming. The attestation is valid from October 5, 2026 to March 31, 2028. The company says it should help sell the value-added fertilizer in organic markets including the United States and grow its sustainable products portfolio.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Look closer
Rated BBB- by CARE- CARE lowered its rating on 26 May 2026.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE BBB- / CARE A3 | Stable | 7 Oct 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 7 Oct 2026 | ▲ Outlook raised | CARE BBB- / CARE A3 Outlook Negative → Stable | Medium | CARE | ₹ 495 Cr. | |
| 26 May 2026 | ▼ Downgrade1 notch | CARE BBB / CARE A3+ → CARE BBB- / CARE A3 | — | CARE | ₹ 495 Cr. | |
| 8 Jan 2026 | ▼ Downgrade | CARE BBB / CARE A3+ | — | CARE | ₹ 495 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 12 Aug 2026 | Financial Results/Other business matters | To consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and three months period ended 30th June 2026. |
| 12 Jun 2026 | Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| 15 May 2026 | Financial Results/Fund Raising/Other business matters | To consider and approve the financial results for the period ended March 31, 2026, Fund Raising and other business matters |
| 12 Feb 2026 | Financial Results/Other business matters | MUKKA : 12-Feb-2026 : The Company has informed the Exchange that a Board meeting to be held on February 10, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 12, 2026, To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 10 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 12 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 332 | 517 | 257 | 172 | 149 | 303 | 382 | 171 | 245 | 654 | 381 | 490 |
| Expenses | 294 | 498 | 224 | 159 | 140 | 262 | 352 | 157 | 224 | 608 | 347 | 443 |
| Operating Profit | 38 | 19 | 32 | 14 | 10 | 41 | 29 | 14 | 20 | 45 | 34 | 47 |
| OPM % | 11% | 3.6% | 13% | 8% | 6% | 14% | 8% | 8% | 8% | 7% | 9% | 10% |
| Other Income | 6 | 8 | 5 | 3 | 4 | 6 | 4 | 3 | 6 | 8 | 15 | 2 |
| Interest | 6 | 6 | 7 | 8 | 9 | 11 | 10 | 11 | 13 | 15 | 15 | 16 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 5 |
| Profit before tax | 35 | 17 | 27 | 6 | 1 | 33 | 20 | 2 | 9 | 35 | 29 | 27 |
| Tax % | 18% | 31% | −8% | 5% | −40% | 19% | 30% | 33% | 26% | 21% | 26% | 32% |
| Net Profit | 29 | 12 | 29 | 5 | 1 | 27 | 14 | 2 | 7 | 27 | 21 | 19 |
| EPS in Rs | 1.28 | 0.48 | 0.91 | 0.14 | 0.07 | 0.88 | 0.45 | 0.05 | 0.2 | 0.79 | 0.69 | 0.63 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 19%
- 3 Years
- 7%
- TTM
- 76%
- 10 Years
- —
- 5 Years
- 53%
- 3 Years
- 6%
- TTM
- 59%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 17%
- 3 Years
- 15%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Mukka Proteins | ₹ 24.43 | — | 10.5x | — | 11% | — |
| Nestle India | ₹ 1,173.45 | ₹ 2,26,278 Cr. | 80.4x | 53.4x | 76.3% | 15.1% |
| Britannia Industries | ₹ 4,547.80 | ₹ 1,09,542 Cr. | 51.5x | 25.5x | 53.6% | 13.3% |
| Tata Consumer Products | ₹ 960.00 | ₹ 95,010 Cr. | 67.4x | 4.9x | 7.4% | 8.1% |
| Godrej Industries | ₹ 918.00 | ₹ 30,884 Cr. | 34.9x | 4x | 11.6% | 10.9% |
| Patanjali Foods | ₹ 351.00 | ₹ 38,193 Cr. | 18.9x | 2.8x | 14.8% | 4.5% |
Management
- Kalandan Mohammed Haris
- Chief Executive Officer, Managing Director, Executive Director
- Kalandan Mohammed Althaf
- Chief Financial Officer, Whole-Time Director
- Kalandan Mohammad Arif
- Chief Operating Officer, Whole-Time Director
- Mehaboobsab Mahmadgous Chalyal
- Compliance Officer, Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.